Theresa Cassidy
Executive Director, Real-World Evidence & Epidemiology Boehringer Ingelheim
Theresa A. Cassidy is Executive Director of Global Epidemiology and Real-World Evidence at Boehringer Ingelheim, leading innovative RWE strategies across CNS and respiratory portfolios. With 20 years of experience spanning public health, epidemiology, and pharmaceutical evidence generation, she specializes in advancing real-world study design to support clinical development, regulatory strategy, and access decisions. Her expertise includes observational research and integrating novel methods including NLP, tokenization, and pragmatic trial design to elevate evidence quality and drive impact across the product lifecycle.
Seminars
Thursday 29th October 2026
Designing Fit for Purpose RWE in Early Development Using Symptom Level Data to Inform Decision Making
1:30 pm
- Working in therapeutic areas like mental health where structured diagnoses are often missing and exploring how symptom level and unstructured data can be used to better define patient populations and unmet needs
- Applying epidemiological thinking in early development to navigate bias, confounding, and data gaps when informing trial design and early decision making
- Sharing practical case examples that show how real-world symptom data can support cohort identification, endpoint selection, and reduce risk earlier in the pipeline
